Wealth Advisors of Iowa’s AbbVie ABBV Stock Holding History

Wealth Advisors of Iowa’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222K	Buy	+882	New	+$190K	0.06%	82
2022 Q3	–	Sell	-4,549	Closed	-$737K	–	56
2022 Q2	$737K	Hold	4,549	–	–	0.13%	51
2022 Q1	$737K	Buy	4,549 +906	+25%	+$132K	0.37%	26
2021 Q4	$493K	Buy	3,643 +783	+27%	+$92.5K	0.27%	33
2021 Q3	$309K	Buy	+2,860	New	+$327K	0.17%	42

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Advisors of Iowa's ABBV Position: Q2 2026 in Review

Wealth Advisors of Iowa opened a new position in AbbVie (ABBV) in Q2 2026: 882 shares worth $222K. The stake represents 0.06% of the portfolio and ranks #82 among its holdings. This is a return to the name: Wealth Advisors of Iowa previously reported a position in ABBV as recently as Q2 2022.

Wealth Advisors of Iowa first reported a position in ABBV in Q3 2021 and has held it in 5 quarters since. The position peaked at $737K in Q2 2022. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Wealth Advisors of Iowa held 882 shares of AbbVie worth $222K as of Q2 2026.
AbbVie was a new Wealth Advisors of Iowa position in Q2 2026.
AbbVie made up 0.06% of Wealth Advisors of Iowa's portfolio in Q2 2026, its #82 holding.
Wealth Advisors of Iowa first reported a position in AbbVie in Q3 2021 and has held it in 5 quarters since.
Wealth Advisors of Iowa's AbbVie position peaked at $737K in Q2 2022.
1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealth Advisors of Iowa's 13F filing for Q2 2026, filed 30 Jul 2026.